Literature DB >> 16598790

Utrophin is a calpain substrate in muscle cells.

Isabelle Courdier-Fruh1, Alexandre Briguet.   

Abstract

Calpains are Ca2+ -dependent cytosolic cysteine proteases that participate in the pathology of Duchenne muscular dystrophy (DMD). Utrophin is a functional homolog of dystrophin that partially compensates for dystrophin deficiency in myofibers of mdx mice. In this study, we investigated the susceptibility of utrophin to cleavage by calpain in vitro and in muscle cells. We found that utrophin is a direct in vitro substrate of purified calpain I and II. Cleavage of utrophin by calpain I or II generates specific degradation products that are also found in cultured control and DMD myotubes under conditions with elevated intracellular Ca2+ levels. In addition, we showed that activation of cellular calpains by Ca2+ ionophore treatment reduces utrophin protein levels in muscle cells and that calpain inhibition prevents this Ca2+ -induced reduction in utrophin levels. These observations suggest that, beside its known effect on general muscle protein degradation, calpain contributes to DMD pathology by specifically degrading the compensatory protein utrophin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598790     DOI: 10.1002/mus.20549

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

Review 1.  Therapeutic approaches to muscular dystrophy.

Authors:  Aurélie Goyenvalle; Jane T Seto; Kay E Davies; Jeffrey Chamberlain
Journal:  Hum Mol Genet       Date:  2011-03-24       Impact factor: 6.150

2.  Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I.

Authors:  Michael Erb; Barbara Hoffmann-Enger; Holger Deppe; Michael Soeberdt; Roman H Haefeli; Christian Rummey; Achim Feurer; Nuri Gueven
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

3.  Long-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscle.

Authors:  Louise H Jørgensen; Alison Blain; Elizabeth Greally; Steve H Laval; Andrew M Blamire; Benjamin J Davison; Heinrich Brinkmeier; Guy A MacGowan; Henrik D Schrøder; Kate Bushby; Volker Straub; Hanns Lochmüller
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy.

Authors:  Martin K Childers; Janet R Bogan; Daniel J Bogan; Hansel Greiner; Melanie Holder; Robert W Grange; Joe N Kornegay
Journal:  Front Pharmacol       Date:  2012-01-09       Impact factor: 5.810

5.  Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin.

Authors:  Surinder M Singh; Justine F Molas; Narsimulu Kongari; Swati Bandi; Geoffrey S Armstrong; Steve J Winder; Krishna M G Mallela
Journal:  Proteins       Date:  2012-02-17

6.  Calpain-mediated proteolysis of tropomodulin isoforms leads to thin filament elongation in dystrophic skeletal muscle.

Authors:  David S Gokhin; Matthew T Tierney; Zhenhua Sui; Alessandra Sacco; Velia M Fowler
Journal:  Mol Biol Cell       Date:  2014-01-15       Impact factor: 4.138

7.  Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts.

Authors:  David W Hammers; Margaret M Sleeper; Sean C Forbes; Ai Shima; Glenn A Walter; H Lee Sweeney
Journal:  J Am Heart Assoc       Date:  2016-08-09       Impact factor: 5.501

8.  Cytoskeletal protein degradation in brain death donor kidneys associates with adverse posttransplant outcomes.

Authors:  Rebecca H Vaughan; Jean-Claude Kresse; Louise K Farmer; Marie L Thézénas; Benedikt M Kessler; Jan H N Lindeman; Edward J Sharples; Gavin I Welsh; Rikke Nørregaard; Rutger J Ploeg; Maria Kaisar
Journal:  Am J Transplant       Date:  2022-02-04       Impact factor: 9.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.